Foretinib (GSK1363089, EXEL-2880, XL-880) is an ATP-competitive inhibitor of HGFR and VEGFR, mostly for Met (c-Met) and KDR with IC50 of 0.4 nM and 0.9 nM in cell-free assays. Less potent against Ron, Flt-1/3/4, Kit (c-Kit), PDGFR?/? and Tie-2, and little activity to FGFR1 and EGFR. Phase 2. *For Research & Development use only. Product is not intended for drug, household, or human consumption.